Kala Bio (KALA) Capital Leases (2018 - 2022)
Kala Bio (KALA) posted Capital Leases of $737000.0 for Q1 2022, up 34.49% sequentially from $548000.0 in Q4 2021, and down 97.32% YoY from $27.5 million in Q1 2021.
Kala Bio (KALA) Capital Leases (2018 - 2022) Analysis & Trends
Kala Bio has reported Capital Leases for 5 years, with the latest figure at $737000.0 in Q1 2022.
- Quarterly Capital Leases fell 97.32% year-over-year to $737000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $737000.0 (down 97.32% YoY) and the FY2021 annual result came in at $548000.0, down 97.98% from the prior year.
- Capital Leases climbed to $737000.0 in Q1 2022 per KALA's latest filing, from $548000.0 in the prior quarter.
- Over five years, Capital Leases peaked at $29.6 million in Q1 2019 and troughed at $548000.0 in Q4 2021.
- A 5-year average of $24.2 million and a median of $27.7 million in 2020 frame the typical range for Capital Leases.
- The sharpest annual moves came in 2019 and 2021: Capital Leases retreated 0.27% in 2019, then plunged 97.98% in 2021.
- Over 5 years, Capital Leases stood at $28.8 million in 2018, then dropped by 0.27% to $28.7 million in 2019, then dropped by 5.34% to $27.1 million in 2020, then slumped by 97.98% to $548000.0 in 2021, then jumped by 34.49% to $737000.0 in 2022.
- According to Business Quant data, Capital Leases over the past three periods registered $737000.0, $548000.0, and $26.7 million for Q1 2022, Q4 2021, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - |
| 10 | Kala Bio | 9.96 Mn | 9.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 737,000.00 |
| Dec 31, 2021 | 548,000.00 |
| Sep 30, 2021 | 26.66 Mn |
| Jun 30, 2021 | 27.06 Mn |
| Mar 31, 2021 | 27.53 Mn |
| Dec 31, 2020 | 27.14 Mn |
| Sep 30, 2020 | 27.55 Mn |
| Jun 30, 2020 | 27.93 Mn |
| Mar 31, 2020 | 28.31 Mn |
| Dec 31, 2019 | 28.67 Mn |
| Sep 30, 2019 | 29.03 Mn |
| Jun 30, 2019 | 29.36 Mn |
| Mar 31, 2019 | 29.59 Mn |
| Dec 31, 2018 | 28.75 Mn |